Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.

Disruption of gene regulation is known to play major roles in carcinogenesis and tumour progression. Here, we comprehensively characterize the mutational profiles of diverse transcription factor binding sites (TFBSs) across 1,574 completely sequenced cancer genomes encompassing 11 tumour types. We a...

Full description

Saved in:
Bibliographic Details
Main Authors: Vera B Kaiser, Martin S Taylor, Colin A Semple
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-08-01
Series:PLoS Genetics
Online Access:https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1006207&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850232112694689792
author Vera B Kaiser
Martin S Taylor
Colin A Semple
author_facet Vera B Kaiser
Martin S Taylor
Colin A Semple
author_sort Vera B Kaiser
collection DOAJ
description Disruption of gene regulation is known to play major roles in carcinogenesis and tumour progression. Here, we comprehensively characterize the mutational profiles of diverse transcription factor binding sites (TFBSs) across 1,574 completely sequenced cancer genomes encompassing 11 tumour types. We assess the relative rates and impact of the mutational burden at the binding sites of 81 transcription factors (TFs), by comparing the abundance and patterns of single base substitutions within putatively functional binding sites to control sites with matched sequence composition. There is a strong (1.43-fold) and significant excess of mutations at functional binding sites across TFs, and the mutations that accumulate in cancers are typically more disruptive than variants tolerated in extant human populations at the same sites. CTCF binding sites suffer an exceptionally high mutational load in cancer (3.31-fold excess) relative to control sites, and we demonstrate for the first time that this effect is seen in essentially all cancer types with sufficient data. The sub-set of CTCF sites involved in higher order chromatin structures has the highest mutational burden, suggesting a widespread breakdown of chromatin organization. However, we find no evidence for selection driving these distinctive patterns of mutation. The mutational load at CTCF-binding sites is substantially determined by replication timing and the mutational signature of the tumor in question, suggesting that selectively neutral processes underlie the unusual mutation patterns. Pervasive hyper-mutation within transcription factor binding sites rewires the regulatory landscape of the cancer genome, but it is dominated by mutational processes rather than selection.
format Article
id doaj-art-8f51262f53e94546a121a48fbebbfbc3
institution OA Journals
issn 1553-7390
1553-7404
language English
publishDate 2016-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj-art-8f51262f53e94546a121a48fbebbfbc32025-08-20T02:03:17ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042016-08-01128e100620710.1371/journal.pgen.1006207Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.Vera B KaiserMartin S TaylorColin A SempleDisruption of gene regulation is known to play major roles in carcinogenesis and tumour progression. Here, we comprehensively characterize the mutational profiles of diverse transcription factor binding sites (TFBSs) across 1,574 completely sequenced cancer genomes encompassing 11 tumour types. We assess the relative rates and impact of the mutational burden at the binding sites of 81 transcription factors (TFs), by comparing the abundance and patterns of single base substitutions within putatively functional binding sites to control sites with matched sequence composition. There is a strong (1.43-fold) and significant excess of mutations at functional binding sites across TFs, and the mutations that accumulate in cancers are typically more disruptive than variants tolerated in extant human populations at the same sites. CTCF binding sites suffer an exceptionally high mutational load in cancer (3.31-fold excess) relative to control sites, and we demonstrate for the first time that this effect is seen in essentially all cancer types with sufficient data. The sub-set of CTCF sites involved in higher order chromatin structures has the highest mutational burden, suggesting a widespread breakdown of chromatin organization. However, we find no evidence for selection driving these distinctive patterns of mutation. The mutational load at CTCF-binding sites is substantially determined by replication timing and the mutational signature of the tumor in question, suggesting that selectively neutral processes underlie the unusual mutation patterns. Pervasive hyper-mutation within transcription factor binding sites rewires the regulatory landscape of the cancer genome, but it is dominated by mutational processes rather than selection.https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1006207&type=printable
spellingShingle Vera B Kaiser
Martin S Taylor
Colin A Semple
Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
PLoS Genetics
title Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
title_full Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
title_fullStr Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
title_full_unstemmed Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
title_short Mutational Biases Drive Elevated Rates of Substitution at Regulatory Sites across Cancer Types.
title_sort mutational biases drive elevated rates of substitution at regulatory sites across cancer types
url https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1006207&type=printable
work_keys_str_mv AT verabkaiser mutationalbiasesdriveelevatedratesofsubstitutionatregulatorysitesacrosscancertypes
AT martinstaylor mutationalbiasesdriveelevatedratesofsubstitutionatregulatorysitesacrosscancertypes
AT colinasemple mutationalbiasesdriveelevatedratesofsubstitutionatregulatorysitesacrosscancertypes